We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · November 10, 2021

Dabrafenib Plus Trametinib as Adjuvant Therapy in Japanese Patients With Advanced Melanoma

Melanoma research


Additional Info

Melanoma research
Retrospective analysis of adjuvant therapy using dabrafenib plus trametinib in Japanese patients with advanced melanoma: analysis of 36 cases
Melanoma Res. 2021 Sep 13;[EPub Ahead of Print], R Amagai, Y Muto, H Kato, S Matsushita, T Maekawa, S Fukushima, K Yoshino, H Uchi, Y Fujisawa, Y Yamamoto, K Ohuchi, Y Kambayashi, T Fujimura

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading